The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
Open accessAbstract
Background: The purpose of this study was to estimate precise age-specific tubo-ovarian carcinoma (TOC) and breast cancer (BC) risks for carriers of pathogenic variants in RAD51C and RAD51D. Methods: We analyzed data from 6178 families, 125 with pathogenic variants in RAD51C, and 6690 families, 60 with pathogenic variants in RAD51D. TOC and BC relative and cumulative risks were estimated using complex segregation analysis to model the cancer inheritance patterns in families while adjusting for the mode of ascertainment of each family. All statistical tests were two-sided. Results: Pathogenic variants in both RAD51C and RAD51D were associated with TOC (RAD51C: relative risk [RR] = 7.55, 95% confidence interval [CI] = 5.60 to 10.19; P = 5 × 10-40; RAD51D: RR = 7.60, 95% CI = 5.61 to 10.30; P = 5 × 10-39) and BC (RAD51C: RR = 1.99, 95% CI = 1.39 to 2.85; P = 1.55 × 10-4; RAD51D: RR = 1.83, 95% CI = 1.24 to 2.72; P = .002). For both RAD51C and RAD51D, there was a suggestion that the TOC relative risks increased with age until around age 60 years and decreased thereafter. The estimated cumulative risks of developing TOC to age 80 years were 11% (95% CI = 6% to 21%) for RAD51C and 13% (95% CI = 7% to 23%) for RAD51D pathogenic variant carriers. The estimated cumulative risks of developing BC to 80 years were 21% (95% CI = 15% to 29%) for RAD51C and 20% (95% CI = 14% to 28%) for RAD51D pathogenic variant carriers. Both TOC and BC risks for RAD51C and RAD51D pathogenic variant carriers varied by cancer family history and could be as high as 32–36% for TOC, for carriers with two first-degree relatives diagnosed with TOC, or 44–46% for BC, for carriers with two first-degree relatives diagnosed with BC. Conclusions: These estimates will facilitate the genetic counseling of RAD51C and RAD51D pathogenic variant carriers and justify the incorporation of RAD51C and RAD51D into cancer risk prediction models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Self-citation
Cited by
Miller, D. T., Lee, K., Abul-Husn, N. S., Amendola, L. M., Brothers, K., Chung, W. K., Gollob, M. H., Gordon, A. S., Harrison, S. M., Hershberger, R. E., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.006 · Cited by 276
Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe
Marmolejo, D. H., Wong, M. Y. Z., Bajalica-Lagercrantz, S., Tischkowitz, M., Balmaña, J., Patócs, A. B., Chappuis, P., Colas, C., Genuardi, M., Haanpää, M., et al. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104350 · Cited by 67
Self-citationHigh-resolution functional mapping of RAD51C by saturation genome editing
Olvera-León, R., Zhang, F., Offord, V., Zhao, Y., Tan, H. K., Gupta, P., Pal, T., Robles-Espinoza, C. D., Arriaga-González, F. G., Matsuyama, L. S. A. S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.039 · Cited by 44
Self-citation
Metadata
- Authors
- Yang, X., Song, H., Leslie, G., Engel, C., Hahnen, E., Auber, B., Horváth, J., Kast, K., Niederacher, D., Turnbull, C., Houlston, R., Hanson, H., Loveday, C., Dolinsky, J. S., LaDuca, H., Ramus, S. J., Menon, U., Rosenthal, A. N., Jacobs, I., Gayther, S. A., Dicks, E., Nevanlinna, H., Aittomäki, K., Pelttari, L. M., Ehrencrona, H., Borg, Å., Kvist, A., Rivera, B., Hansen, T. V. O., Djursby, M., Lee, A., Dennis, J., Bowtell, D. D., Traficante, N., Diez, O., Balmaña, J., Gruber, S. B., Chenevix-Trench, G., Investigators, K., Jensen, A., Kjær, S. K., Høgdall, E., Castéra, L., Garber, J., Janavicius, R., Osorio, A., Golmard, L., Vega, A., Couch, F. J., Robson, M., Gronwald, J., Domchek, S. M., Culver, J. O., de la Hoya, M., Easton, D. F., Foulkes, W. D., Tischkowitz, M., Meindl, A., Schmutzler, R. K., Pharoah, P. D. P., & Antoniou, A. C.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-28
- Volume
- 112
- Issue
- 12
- Pages
- 1242-1250
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W3007067759
- Cited by
- 175
- References
- 1
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.